F. Lelong

615 total citations
21 papers, 473 citations indexed

About

F. Lelong is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, F. Lelong has authored 21 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Genetics and 4 papers in Genetics. Recurrent topics in F. Lelong's work include Hemoglobinopathies and Related Disorders (4 papers), Blood groups and transfusion (4 papers) and Retinal Diseases and Treatments (3 papers). F. Lelong is often cited by papers focused on Hemoglobinopathies and Related Disorders (4 papers), Blood groups and transfusion (4 papers) and Retinal Diseases and Treatments (3 papers). F. Lelong collaborates with scholars based in France and United States. F. Lelong's co-authors include A. Glacet–Bernard, G. Coscas, A. Chabanel, M Samama, Bernard‐Jean Paniel, Michel Rugina, D. Jannet, Jacques Milliez, Michel Meyer Samama and Habib Latrous and has published in prestigious journals such as The American Journal of Medicine, Ophthalmology and American Journal of Obstetrics and Gynecology.

In The Last Decade

F. Lelong

20 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Lelong France	11	258	139	119	66	49	21	473
Pınar Aydin Türkiye	14	325 1.3×	81 0.6×	25 0.2×	119 1.8×	73 1.5×	39	496
L.L. Hansen Germany	12	401 1.6×	203 1.5×	35 0.3×	12 0.2×	71 1.4×	36	495
J. S. Kennerdell United States	15	232 0.9×	31 0.2×	21 0.2×	79 1.2×	214 4.4×	28	665
Francesca Gianniello Italy	13	40 0.2×	24 0.2×	209 1.8×	73 1.1×	96 2.0×	22	463
Esra Ayhan Tuzcu Türkiye	11	197 0.8×	110 0.8×	9 0.1×	16 0.2×	30 0.6×	38	347
G. Tokgöz Türkiye	10	170 0.7×	33 0.2×	50 0.4×	179 2.7×	21 0.4×	24	345
Goldberg Mf United States	14	190 0.7×	66 0.5×	115 1.0×	16 0.2×	103 2.1×	28	478
Waheeda Rahman United Kingdom	10	443 1.7×	322 2.3×	8 0.1×	56 0.8×	15 0.3×	19	610
Koki Yamada Japan	12	80 0.3×	73 0.5×	85 0.7×	6 0.1×	21 0.4×	28	441
Nurettin Akyol Türkiye	13	299 1.2×	108 0.8×	21 0.2×	50 0.8×	14 0.3×	31	468

Countries citing papers authored by F. Lelong

Since Specialization

Citations

This map shows the geographic impact of F. Lelong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lelong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lelong more than expected).

Fields of papers citing papers by F. Lelong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Lelong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lelong. The network helps show where F. Lelong may publish in the future.

Co-authorship network of co-authors of F. Lelong

This figure shows the co-authorship network connecting the top 25 collaborators of F. Lelong. A scholar is included among the top collaborators of F. Lelong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Lelong. F. Lelong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bernaudin, Françoise, Cécile Arnaud, Annie Kamdem, et al.. (2022). S112: COMPARATIVE SCORE OF HOWELL-JOLLY BODIES IN SICKLE CELL DISEASE PATIENTS ACCORDING TO GENOTYPE, AGE, SPLENECTOMY OR STEM CELL TRANSPLANTATION HISTORY. HemaSphere. 6. 7–7. 1 indexed citations

Chadebech, Philippe, Gwellaouen Bodivit, F. Lelong, et al.. (2021). Les cytokines plasmatiques chez les patients drépanocytaires comme marqueurs prédictifs de survenue des hémolyses transfusionnelles retardées. Transfusion Clinique et Biologique. 28(4). S113–S113.

Chadebech, Philippe, Gwellaouen Bodivit, Sadaf Pakdaman, et al.. (2020). Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactions. Cytokine. 136. 155259–155259. 3 indexed citations

Bernaudin, Françoise, Cécile Arnaud, Annie Kamdem, et al.. (2018). Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea. Blood Advances. 2(6). 626–637. 19 indexed citations

Gérard‐Blanluet, Marion, Serge Romana, Marc Le Lorc’h, et al.. (2004). Classical West “syndrome” phenotype with a subtelomeric 4p trisomy. American Journal of Medical Genetics Part A. 130A(3). 299–302. 10 indexed citations

Glacet–Bernard, A., et al.. (2003). [Retinal vein occlusion and hyperhomocysteinemia].. PubMed. 26(3). 249–53. 12 indexed citations

Rugina, Michel, et al.. (2002). High‐titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors. American Journal of Hematology. 71(1). 33–36. 28 indexed citations

Gérard‐Blanluet, Marion, Claude Danan, Martine Sinico, et al.. (2002). Mosaic trisomy 9 and lobar holoprosencephaly. American Journal of Medical Genetics. 111(3). 295–300. 12 indexed citations

Glacet–Bernard, A., et al.. (1998). [Retinal vein occlusion and lipoprotein (a)].. PubMed. 21(4). 245–50. 4 indexed citations

10.

Glacet–Bernard, A., et al.. (1996). Prognostic Factors for Retinal Vein Occlusion. Ophthalmology. 103(4). 551–560. 171 indexed citations

11.

Glacet–Bernard, A., et al.. (1994). A Randomized, Double-Masked Study on the Treatment of Retinal Vein Occlusion With Troxerutin. American Journal of Ophthalmology. 118(4). 421–429. 67 indexed citations

12.

Lelong, F., et al.. (1994). A case of peroxidase‐positive acute leukaemia expressing only T lineage lymphoid markers. British Journal of Haematology. 86(1). 195–197. 2 indexed citations

13.

Glacet–Bernard, A., A. Chabanel, F. Lelong, Michel Meyer Samama, & G. Coscas. (1994). Elevated Erythrocyte Aggregation in Patients with Central Retinal Vein Occlusion and without Conventional Risk Factors. Ophthalmology. 101(9). 1483–1487. 36 indexed citations

14.

Chariot, Patrick, et al.. (1991). Systemic mast cell disease associated with primary mediastinal germ cell tumor. The American Journal of Medicine. 90(3). 381–385. 20 indexed citations

15.

Milliez, Jacques, et al.. (1991). The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. American Journal of Obstetrics and Gynecology. 165(1). 51–56. 56 indexed citations

16.

Chariot, Patrick, et al.. (1991). Systemic mast cell disease associated with primary mediastinal germ cell tumor. The American Journal of Medicine. 90(1). 381–385. 3 indexed citations

17.

Glacet–Bernard, A., G. Coscas, F. Lelong, et al.. (1989). [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].. PubMed. 89(12). 1393–6. 4 indexed citations

18.

Abuaf, N, et al.. (1987). La valeur diagnostique des anticorps anti-ADN dépend de la technique utilisée pour leur dépistage. La Revue de Médecine Interne. 8(2). 157–162. 3 indexed citations

19.

Habibi, B., et al.. (1980). [Red cell autoimmunization in a "normal" population. 63 cases (author's transl)].. PubMed. 9(43). 3253–7. 4 indexed citations

20.

Lelong, F. & Georges Millot. (1966). Sur l'origine des minéraux micacés des altérations latéritiques. Diagenèse régressive -Minéraux en transit. 19(3). 271–286. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact